Abstract
Purpose: This cross-sectional study aims to assess the recruitment and retention strategies employed for underserved populations in diabetic retinopathy (DR) clinical trials.
Methods: We searched relevant clinical trials using two medical databases, MEDLINE (PubMed) and Embase (Elsevier). Inclusion criteria included studies published between January 1, 2018, and December 30, 2023, focused on DR, and conducted in countries with an Ethnic Fractionalization Index (EFI) of ≥ 0.3. Screening and data extraction was performed independently by three authors.
Results: A total of 32 articles were analyzed. None of these articles employed specific recruitment strategies for underserved populations. Only 3 of the articles included retention strategies, and just 3 mentioned the challenges or limitations encountered in recruiting underserved individuals.
Conclusion: Our study highlights a significant deficiency in the recruitment and retention strategies for marginalized groups in DR clinical trials. Bridging these gaps is essential to enhance the generalizability and applicability of trial findings, ultimately leading to the standardization of DR treatments. This advancement will significantly benefit inequitable populations, ensuring they receive the full potential of medical advancements.
Methods: We searched relevant clinical trials using two medical databases, MEDLINE (PubMed) and Embase (Elsevier). Inclusion criteria included studies published between January 1, 2018, and December 30, 2023, focused on DR, and conducted in countries with an Ethnic Fractionalization Index (EFI) of ≥ 0.3. Screening and data extraction was performed independently by three authors.
Results: A total of 32 articles were analyzed. None of these articles employed specific recruitment strategies for underserved populations. Only 3 of the articles included retention strategies, and just 3 mentioned the challenges or limitations encountered in recruiting underserved individuals.
Conclusion: Our study highlights a significant deficiency in the recruitment and retention strategies for marginalized groups in DR clinical trials. Bridging these gaps is essential to enhance the generalizability and applicability of trial findings, ultimately leading to the standardization of DR treatments. This advancement will significantly benefit inequitable populations, ensuring they receive the full potential of medical advancements.
Original language | American English |
---|---|
Pages | 30 |
State | Published - 13 Sep 2024 |
Event | 2024 Symposium on Tribal and Rural Innovations in Disparities and Equity for Health - Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation, Tahlequah, United States Duration: 13 Sep 2024 → 13 Sep 2024 |
Conference
Conference | 2024 Symposium on Tribal and Rural Innovations in Disparities and Equity for Health |
---|---|
Abbreviated title | STRIDE 2024 |
Country/Territory | United States |
City | Tahlequah |
Period | 13/09/24 → 13/09/24 |